Combined Metabolic Activator Supplementation in Subjects Diagnosed With Alzheimer's Disease

Clinical trial NCT07062198 · RECRUITING

Trial details

NCT number: NCT07062198
Sponsor: ScandiBio Therapeutics AB
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2025-09-12
Primary completion: 2026-09-01
Enrollment: 845

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.